184 related articles for article (PubMed ID: 31324467)
1. Torque teno virus viremia in patients with chronic arthritis: Influence of biologic therapies.
Martín-López M; Albert E; Fernández-Ruiz M; González-Álvaro I; Rodríguez E; Aguado JM; Navarro D; Pablos JL
Semin Arthritis Rheum; 2020 Feb; 50(1):166-171. PubMed ID: 31324467
[TBL] [Abstract][Full Text] [Related]
2. Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis.
Studenic P; Bond G; Kerschbaumer A; Bécède M; Pavelka K; Karateev D; Stieger J; Puchner R; Mueller RB; Puchhammer-Stöckl E; Durechova M; Loiskandl M; Perkmann T; Olejarova M; Luchikhina E; Steiner CW; Bonelli M; Smolen JS; Aletaha D
Rheumatology (Oxford); 2022 Jul; 61(7):2815-2825. PubMed ID: 34792562
[TBL] [Abstract][Full Text] [Related]
3. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.
Yun H; Xie F; Delzell E; Levitan EB; Chen L; Lewis JD; Saag KG; Beukelman T; Winthrop KL; Baddley JW; Curtis JR
Arthritis Rheumatol; 2016 Jan; 68(1):56-66. PubMed ID: 26315675
[TBL] [Abstract][Full Text] [Related]
4. Torque Teno Virus Is Associated With the State of Immune Suppression Early After Liver Transplantation.
Ruiz P; Martínez-Picola M; Santana M; Muñoz J; Pérez-Del-Pulgar S; Koutsoudakis G; Sastre L; Colmenero J; Crespo G; Navasa M
Liver Transpl; 2019 Feb; 25(2):302-310. PubMed ID: 30375165
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
Silvagni E; Bortoluzzi A; Carrara G; Zanetti A; Govoni M; Scirè CA
BMJ Open; 2018 Sep; 8(9):e021447. PubMed ID: 30206082
[TBL] [Abstract][Full Text] [Related]
6. Torque Teno Virus Viral Load as a Marker of Immune Function in Allogeneic Haematopoietic Stem Cell Transplantation Recipients.
Mouton W; Conrad A; Bal A; Boccard M; Malcus C; Ducastelle-Lepretre S; Balsat M; Barraco F; Larcher MV; Fossard G; Labussière-Wallet H; Ader F; Brengel-Pesce K; Trouillet-Assant S; Heminf Study Group L
Viruses; 2020 Nov; 12(11):. PubMed ID: 33187285
[TBL] [Abstract][Full Text] [Related]
7. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
Shepherd J; Cooper K; Harris P; Picot J; Rose M
Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Torque Teno Virus in hemodialysis and renal transplant patients in Australia: A cross-sectional study.
Davis JS; Chu G; Pathinayake P; Jones D; Giffard P; Macera L; Choi P; Bartlett NW
Transpl Infect Dis; 2020 Oct; 22(5):e13400. PubMed ID: 33462980
[TBL] [Abstract][Full Text] [Related]
10. Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry.
Sebastiani M; Venerito V; Bugatti S; Bazzani C; Biggioggero M; Petricca L; Foti R; Bortoluzzi A; Balduzzi S; Visalli E; Frediani B; Manfredi A; Gremese E; Favalli E; Iannone F; Ferraccioli G; Lapadula G;
Clin Rheumatol; 2021 Oct; 40(10):4039-4047. PubMed ID: 33881676
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study.
Pascart T; Philippe P; Drumez E; Deprez X; Cortet B; Duhamel A; Houvenagel E; Flipo RM
Int J Rheum Dis; 2016 Nov; 19(11):1093-1102. PubMed ID: 27018857
[TBL] [Abstract][Full Text] [Related]
12. The Value of Torque Teno Virus (TTV) as a Marker for the Degree of Immunosuppression in Adult Patients after Hematopoietic Stem Cell Transplantation (HSCT).
Schmitz J; Kobbe G; Kondakci M; Schuler E; Magorsch M; Adams O
Biol Blood Marrow Transplant; 2020 Apr; 26(4):643-650. PubMed ID: 31712192
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept.
Hirota T; Suzuki T; Ogishima H; Hagiwara S; Ebe H; Takahashi H; Yokosawa M; Umeda N; Kondo Y; Tsuboi H; Matsumoto I; Sumida T
Mod Rheumatol; 2016; 26(1):29-35. PubMed ID: 26140463
[TBL] [Abstract][Full Text] [Related]
14. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
Nisar MK; Rafiq A; Östör AJ
Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Bae SC
Int J Rheum Dis; 2016 Nov; 19(11):1103-1111. PubMed ID: 26692536
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.
Kubo S; Nakayamada S; Nakano K; Hirata S; Fukuyo S; Miyagawa I; Hanami K; Saito K; Tanaka Y
Ann Rheum Dis; 2016 Jul; 75(7):1321-7. PubMed ID: 26245754
[TBL] [Abstract][Full Text] [Related]
17. Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.
Schäfer M; Meißner Y; Kekow J; Berger S; Remstedt S; Manger B; Listing J; Strangfeld A; Zink A
Rheumatology (Oxford); 2020 Aug; 59(8):1916-1926. PubMed ID: 31745566
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.
Albert E; Solano C; Pascual T; Torres I; Macera L; Focosi D; Maggi F; Giménez E; Amat P; Navarro D
J Clin Virol; 2017 Sep; 94():22-28. PubMed ID: 28710997
[TBL] [Abstract][Full Text] [Related]
19. Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.
Wadström H; Frisell T; Askling J;
JAMA Intern Med; 2017 Nov; 177(11):1605-1612. PubMed ID: 28975211
[TBL] [Abstract][Full Text] [Related]
20. Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection.
van Rijn AL; Wunderink HF; Sidorov IA; de Brouwer CS; Kroes AC; Putter H; de Vries AP; Rotmans JI; Feltkamp MC
J Clin Virol; 2021 Jul; 140():104871. PubMed ID: 34089977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
